← Open Payments lookup

ALISON SMITH: Open Payments

NPI 1992223739 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$549 in 23 payments from 12 companies in 2025. Trend: 2023 $243 · 2024 $270 · 2025 $549

Food & beverage: $549
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP3$157
Mallinckrodt Hospital Products Inc.4$90
Novo Nordisk Inc4$69
Novartis Pharmaceuticals Corporation2$51
Fresenius USA Marketing, Inc.2$44
SCPHARMACEUTICALS INC.2$36
AKEBIA THERAPEUTICS INC1$20
Calliditas Therapeutics US Inc.1$20
ABBVIE INC.1$18
Vifor Pharma, Inc.1$16

Products named: LOKELMA, ACTHAR, FARXIGA, Ozempic, VELPHORO, FUROSCIX, Vanrafia, Fabhalta.

Industry payments across LA — which companies pay providers there.